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Background:  Studies  of the  prevalence  of  HIV  in sentinel  populations  are  one  of  the  key strategies  to
monitor  the  HIV  epidemic.  We  describe  HIV prevalence  trends  and identify  differences  across  time  in the
sociodemographic  characteristics  of HIV-infected  women  giving  birth  in Catalonia.
Methods:  We  used  dried  blood  specimens,  residual  to newborn  screening,  which  have  been  collected
in  Catalonia  every  2 months  since  1994.  The  total  number  of samples  obtained  until  2009  and  in  2013
represented  half  of  yearly  newborns.  From  2010  to 2012,  the  total  number  of  samples  obtained  repre-
sented  a quarter  of  yearly  newborns.  We  studied  the  prevalence  by  year  and  place  of current  residence
(Barcelona-city,  cities  >  200,000  inhabitants  and cities  ≤ 200,000  inhabitants)  and  by the  mother’s  birth
country.  A total  of  624,912  infants  were  tested  for HIV  antibodies  from  January  1994 to December  2013.
Results:  HIV  prevalence  trends  among  women  giving  birth  in  Catalonia  decreased  until  2007.  Thereafter,
there  was  a change  to a  steady  trend  until  2013.  However,  among  foreign  women  giving birth  and  living
in  cities  ≤ 200,000  inhabitants,  the  prevalence  of HIV increased  from  2007  to  2013.
Conclusion:  To ensure  early  identiﬁcation  and  treatment  of  HIV-infected  mothers,  it is essential  to main-
tain  HIV  surveillance  programs  and  pre-  and post-natal  screening  programs,  both  in  Barcelona  and  in
cities  with 200,000  inhabitants  or less,  especially  in  immigrant  women.
©  2014  SESPAS.  Published  by  Elsevier  España,  S.L.U.  All rights  reserved.
Veinte  an˜os  de  seguimiento  de  la  prevalencia  del  VIH  y  características
sociodemográﬁcas  en  mujeres  que  dan  a  luz  en  Catalun˜a  (Espan˜a)
alabras clave:
nfecciones por VIH
eroprevalencia de VIH
ujeres embarazadas
rigen étnico y salud
r  e  s  u  m  e  n
Antecedentes:  Los  estudios  de  prevalencia  del  VIH  en  poblaciones  centinela  son  una  de  las  estrategias
clave  para  monitorizar  la  epidemia.  Describimos  tendencias  de la  prevalencia  de  VIH  e identiﬁcamos
diferencias  en el  tiempo  y según  las características  socio-demográﬁcas  de  las  mujeres  que  dan  a  luz
infectadas  por  el  VIH  en  Catalun˜a.
Métodos:  Utilizamos  muestras  de  sangre  seca,  residuales  al cribado  de  recién  nacidos  que  se  recoge  cada
dos meses  desde  el an˜o  1994.  El total  de  muestras  obtenidas  hasta  el  2009  y  en  2013,  representa  la mitad
de los  recién  nacidos  anuales.  En  los an˜os  2010  a 2012,  el  total de  muestras  obtenidas  representa  un
cuarto  de  los recién  nacidos  anuales.  Estudiamos  la  prevalencia  por  an˜o  y  lugar  de residencia  (Barcelona-
ciudad,  ciudades  de  más  de  200.000  habitantes  y otras  ciudades  o pueblos  de  ≤  a  200.000  habitantes)  y
por  lugar  de  nacimiento  de  la  madre.  Entre  enero  1994  y diciembre  2013,  fueron  cribados  de  existencia
de  anticuerpos  anti-VIH  624.912  recién  nacidos.
Resultados:  La  prevalencia  de  VIH  en  las  mujeres  que  dan  a luz en  Catalun˜a  decrece  hasta  el  an˜o  2007,
estabilizándose  en  2013.  Sin  e
≤  a 200.000  habitantes  la  prev
Conclusión:  Es fundamental  m
ciudad  y ciudades  de  ≤  a 200.0
un  temprano  abordaje  de  las  in
©  2014  SES
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http://dx.doi.org/10.1016/j.gaceta.2015.01.012
213-9111/© 2014 SESPAS. Published by Elsevier España, S.L.U. All rights reserved.mbargo,  entre  las  extranjeras  que  dieron  a luz  y que  viven  en  ciudades  de
alencia  de  VIH  aumenta  entre  2007  y 2013.
antener  la  vigilancia  del  VIH  y  los programas  pre  y post  natal  en Barcelona
00  habitantes,  y especialmente  en  las  mujeres  extranjeras  para  asegurar
fectadas  por el  VIH.
PAS.  Publicado  por  Elsevier  España,  S.L.U.  Todos  los  derechos  reservados.
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Studies in sentinel populations to estimate HIV prevalence
re the key strategies to monitor the epidemic 1. Pregnant women
re an important group to target for HIV prevention as early
iagnosis and appropriate management reduces mother to child
ransmission. Monitoring HIV prevalence in this group has been
one using different methods such as back projection from reported
ases of AIDS due to perinatally acquired HIV infection 2 or unlinked
nonymous surveillance 3–7 or testing programs in antenatal care
r abortion clinics 8.
In Catalonia, estimations of pregnant women’s HIV prevalence
annot be done from information collected in antenatal care or
bortion clinics because the standard HIV surveillance question-
aire doesn’t ask about pregnancy status. Unlinked anonymous
esting was introduced in the Integrated Surveillance System of
IV/AIDS/STI of the Health Department (Generalitat de Catalunya)
n 1994, as a way to monitorize HIV prevalence with the mini-
um  participation bias, in key populations. Originally, Intravenous
rug Users, Men  who have Sex with Men  and Female Sex Work-
rs were chosen as high risk populations. Since the offering
f an HIV test to all pregnant women was mandatory in the
ocal protocol, and since a newborn metabolic screening pro-
ram was in place with a very high coverage (99%), newborns
ere also included as a sentinel population to estimate HIV
revalence among pregnant women. The unlinked anonymous
ewborn survey has provided information on HIV prevalence
y area of residence since 1994 and by country of origin since
007 and now includes approximately 50% of live births in Cat-
lonia. The survey includes women whose HIV infection has
lready been diagnosed as well as those unaware of their infec-
ion, giving a measure of overall HIV prevalence in pregnant
omen.
The increase of immigration occurred in Spain and Catalonia
ithin the last 20 years with a steady trend of migrants since the
ear 2009. The pattern of migration of women 15 to 64 years old
s similar, both in big and small cities, increasing up to 2009 and
table after then. Percentages of migrant women are the highest
n Barcelona, followed by 4 cities > 200,000 (Badalona, Hospitalet
e Llobregat, Terrassa and Sabadell) and cities ≤ 200,000 inhabi-
ants.
According to these data, it is meaningful to study the HIV preva-
ence by mother’s country of birth and place of current residence.
ther researchers have studied serological markers of HIV and
ther infections in Spain 9,10. The study of the geographic dis-
ribution of HIV prevalence in women giving birth may  be an
dditional tool to help targeting geographic areas for intervention.
lthough ecological studies are not conclusive 11, taking proﬁt of
ata already available helps reducing costs and better targeting for
urther studies. The aim of this study was to describe HIV preva-
ence trends in women giving birth and identify differences on their
ocio-demographic characteristics by place of current residence in
atalonia during a 20 years period (1994 to 2013) as well as describe
he potential role of immigration more speciﬁcally for the period
007 to 2013.
ethods
ollection of samples
The neonatal dried blood spot survey, residual to newborn
creening 12, takes left over dried blood spots taken from newborn
 days after birth and tests them for maternal HIV infection. These
lood specimens are being collected, in order to avoid seasonality,
very two months. The obtained sample size represents half of theit. 2015;29(5):347–352
yearly newborns up to the year 2009 and also for the year 2013.
Samples from 2009 to 2012 represent only a quarter of the yearly
new born 13 in Catalonia. All samples are irreversibly unlinked
and anonymized prior to HIV testing. Anonymity was guaranteed
by using a computer-aided coding process at the Neonatal Early
Detection Program therefore, the results of HIV antibody testing
can’t be linked with any patient identiﬁcation number. Regional
distribution of yearly samples within Catalonia is proportional to
regional birth rate.
Variables
Variables collected in the study were: HIV results from test-
ing new born as a surrogate of HIV status of the mother (100%
completion), age (100% completion), mother’s country or region of
birth (from 2007) (>95% completion) and mother’s place of current
residence (99.6% completion). In order to allow comparisons we
established three categories of mother’s place of current residence:
Barcelona city, cities >200,000 (Hospitalet de Llobregat, Terrassa,
Sabadell and Badalona) and cities or towns ≤ 200,000 inhabitants.
Mother’s country or region of birth was grouped into Latin
America, Sub-Saharan Africa, Spain and rest of the world.
As background information, population data by country of birth
were collected from the Annual statistical report of Catalonia. Cata-
lan Institute of Statistics13 and classiﬁed according to populations’
origin (Spanish and foreign born) and grouped by categories used
to study mother’s place of current residence: Barcelona city (more
than 1.5 million inhabitants), cities > 200,000 and cities or towns ≤
200,000 inhabitants.
Laboratory methods
Two drops of blood were collected on ﬁlter paper discs (Schle-
icher and Schuell no. 903TM, Dassel, Germany) and stored at
4 ◦C until used. HIV antibodies were determined using a modi-
ﬁed Serodia IgG antibody-capture particle agglutination test for
HIV-1 (Fujirebio Diagnostics) 14. Positive samples were sent to
the Microbiological Service of the University Hospital Germans
Trias I Pujol to conﬁrm the results using an IgG antibody cap-
ture ELISA for HIV-1 and HIV-2. Until 2001 this was done using
the GACELISA test (Murex, UK) 15. In 2002 up to 2006, this con-
ﬁrmatory test was  replaced with the Pasteur HIV-1/2 GenElavia
Mixt ELISA (BioRad, Spain) after checking that normal and exter-
nal valid values were similar for both tests 16. From 2007 to 2009,
the test used was BED-CEIA Assay (Calypte Biomedical Inc, Port-
land, OR, USA) and from 2010 until nowadays, Vitros HIV1 + 2
Reagent (Ortho Clinical Diagnostics Inc, Cardiff, Wales, UK) is the
test used. The surveys are conducted in collaboration with the
Catalan Neonatal Early Detection Programme, Service of Biochem-
istry and Molecular Genetics, Hospital Clinic, Faculty of Medicine,
Barcelona, Spain, as well as with the Microbiology Laboratory of
the Hospital Germans Trias i Pujol, where reactive samples are
conﬁrmed.
Statistical analysis
The annual HIV prevalence among women  giving birth was  com-
puted as the number of HIV-positive samples divided by the total
number of HIV-positive and HIV-negative samples tested each year.
Conﬁdence intervals for proportions were calculated by using the
Clopper and Pearson method. The Cochran-Armitage test was used
as a test for trends of proportions with a 0.05 signiﬁcance level.
Statistical comparisons of prevalence between country or region of
birth were performed using chi-squared analysis and Fisher’s exact
test.
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A total of 624,912 infants were tested for HIV antibodies dur-
ng the 20 years studied (1994-2013). We  present the evolution
f the population of women aged 15 to 64 years provided that
he age range of women giving birth from whom blood samples
ere taken was 10 to 56 years old. The annual number of live
irths is also presented to help the interpretation of HIV preva-
ence.
Due to reductions in ﬁnancial support, the number of HIV tests
erformed was reduced during the period 2008 to 2012, although
he distribution of samples tested by the mother’s place of current
esidence has been maintained overtime.
Data were analyzed using SAS v 9.3
esults
During the twenty years of study, the number of live births
n Catalonia has been rising up to 89,327 in the year 2008 17
nd thereafter decreasing to 71,771 in 2013 18,19 In both, Span-
sh and foreign born mothers, the number of live births increased
p to the year 2008 and decreased mainly in Spanish mothers18,19
p to 2010. From 2010 until 2013, there was a 5.9% and 1.7%
eduction of foreign and autochthonous live births, respectively.
edian age of mothers is 31 years (interquartile range: 28 to
4) being foreign mothers, slightly younger than autochthonous
nd no differences were found by mother’s place of current
esidence.
Despite changes in population numbers overtime, there were no
ariations across the geographical categories of cities established
y our study.During 1994 to 2007, HIV prevalence trends among
omen giving birth in all Catalonia are decreasing from
.32% (95%CI:0.25-0.40) to 0.15% (95%CI:0.12-0.20) (p < 0.0001)
Figure 1). In Barcelona city trends are decreasing (p < 0.05) from
able 1
IV prevalence in women giving birth in Catalonia, by place of current residence. 1994-2
Place of current residence HIV + N tes
Barcelona city 312 1231
Cities >200,000 inhabitants 162 798
Cities ≤ 200,000 inhabitants 654 3978men  giving birth in Catalonia, 1994-2013.
0.43%(95%CI:0.27-0.64) to 0.23% (95%CI:0.14-0.37) as well as in
cities > 200,000 inhabitants (p < 0.005), from 0.43% (95%CI:0.23-
0.73) to 0.20%(95%CI:0.10-0.36) and in cities ≤ 200,000 inhabitants
(p < 0.0001), from 0.25% (95%CI:0.18-0.35) to 0.13%(95%CI:0.09-
0.17), but from 2008 onwards the trend is steady in each
geographical category.
In summary, for all the 20 years’ period, HIV prevalence of all
women giving birth is higher in Barcelona city than the rest of the
Catalan cities (Table 1).
Information about country of birth was only available from 2007
to 2013. During this period the number of women aged 15 to 64
years living in Catalonia increased by 2% as well as the number of
foreign women  of this age group.
In the city of Barcelona and other cities > 200,000 inhabitants,
the number of women aged 15 to 64 years decreased slightly, by
0.2% and 0.3%, respectively. While it increased by 4% in cities ≤
200,000 inhabitants. The percentage of foreign women  over the
total number of women of this age group increased everywhere, by
2% in Barcelona city and by 3% in the other two categories of cities
(> and ≤ to 200,000 inhabitants).
Over the years 2007-2013, foreign women giving birth and
living in any of the geographical categories of cities established
in our study, showed higher HIV prevalence (0.26%) than Span-
ish women  (0.10%). The highest (0.28%) and lowest (0.09%) levels
of HIV prevalence were found in cities ≤ 200,000 inhabitants
among foreign and Spanish women  giving birth, respectively
(Table 2).
In all Catalonia, the 7 years period HIV prevalence was  higher
among women  born in Sub-Saharan Africa (0.40%) followed by Latin
Americans (0.20%) (Table 3).
When looking at the current place of residence, the highest HIV
prevalence was found in women from Sub-Saharan Africa (0.59%)
(p < 0.001) and living in Barcelona city or in cities ≤ 200,000
013.
t HIV prevalence % 95%CI
77 0,25 0,23-0,28
64 0,20 0,17-0,24
42 0,16 0,15-0,17
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Table 2
HIV prevalence in women  giving birth in Catalonia, by country of birth and place of current residence. 2007-2013.
Country of birth Foreign born Spanish born
Place of current residence N test HIV + HIV prevalence % (95%CI) N test HIV + HIV prevalence % (95%CI) P values
Barcelona city 10682 25 0.23 (0.15-0.35) 23037 33 0.14 (0.10-0.20) 0.06
Cities  >200,000 inhabitants 7642 13 0.17 (0.09-0.29) 16110 22 0.14 (0.09-0.21) 0.529
Cities  ≤ 200,000 inhabitants 34184 96 0.28 (0.23-0.34) 94109 83 0.09 (0.07-0.11) <0.001
Table 3
HIV prevalence in women  giving birth in Catalonia, by country or region of birth. 2007-2013.
Country or region of birth Test N HIV + HIV Prevalence % (95%CI)
Spain 133256 138 0,10 (0,09-0,12)
Northern & Sub-Saharan Africa* 20641 82 0,40 (0,32-0,49)
Latin  America** 15827 31 0,20 (0,13-0,28)
Rest  of the world 16040 21 0,13 (0,08-0,20)
* Countries of Northern & Sub-Saharan Africa in this study are the following: Morocco, Algeria, Tunisia, Burkina Faso, Cameroon, The Gambia, Equatorial Guinea, Ghana,
M
razil,
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Uali,  Mauritania, Mozambique, Niger, Nigeria, Senegal and Sudan
** Countries of Latin America in this study are the following: Argentina, Bolivia, B
ruguay.
nhabitants, (0.40%), (p < 0.0001) followed by those from Latin
merica and living in Barcelona city (0.29%) (p < 0.001) (Table 4).
iscussion
HIV prevalence among women giving birth in Catalonia is cur-
ently low (0.12% in 2013), although a signiﬁcant difference was
ound on comparing Spanish and foreign born women  from HIV
ndemic areas. As stated by a recent ECDC report 20, between
007 and 2011 migrant populations in Europe are disproportion-
lly affected by HIV, although there might be signiﬁcant variations
etween countries.
We  may  hypothesize that due to the economical crisis starting in
008, economically and socially deprived populations (foreign and
utochthonous) living in big cities may  have moved to smaller cities
here living conditions are easier and less expensive, consequently
ncreasing the social needs in these areas.
Also, to be considered is the reduction of the number of births
n Catalonia, starting in 2009, from 89,327 new born in 2008 to
1,137 in 2011. Major reductions are among births in the foreign
opulation: from the year 2010 to 2011 there was a 5.9% and 1.7%
eduction of, foreign and autochthonous births, respectively. Nev-
rtheless, these reductions don’t seem to affect the HIV prevalence
stimations.In any case, the fact that highest HIV prevalence is found among
ub-Saharan Africa and Latin-America women giving birth and
iving in Barcelona or in towns and cities ≤ 200,000 inhabitants,
ndicates that HIV surveillance, antenatal and mother’s care have
able 4
IV prevalence in women  giving birth in Catalonia by country or region of birth and plac
Country or region
of birth
Spain Sub-Saharan Afric
Place of current
residence
Test N HIV + HIV Prevalence
% (95%CI)
Test N HIV + HIV Preva
% (95%CI)
Barcelona city 23037 33 0,14 (0,10-0,20) 1362 8 0,59 (0,25
Cities  >200,000
inhabitants
16110 22 0,14 (0,09-0,21) 2691 8 0,03 (0,01
Cities  ≤ 200,000
inhabitants
94109 83 0,09 (0,07-0,11) 16588 66 0,40 (0,31
* Countries of Northern & Sub-Saharan Africa in this study are the following: Morocco
ali,  Mauritania, Mozambique, Niger, Nigeria, Senegal and Sudan.
** Countries of Latin America in this study are the following: Argentina, Bolivia, Brazil,
ruguay. Chile, Colombia, Cuba, Dominican Republic, Ecuador, Panama, Paraguay, Peru and
to be maintained and enhanced in both Catalan geographical areas,
with special attention to address cultural and language barriers, in
order to ensure proper identiﬁcation and timely treatment of HIV
infected mothers.
In Catalonia, differently to UK 21, it is unknown whether foreign
born citizens living with HIV are less likely to access healthcare,
mainly due to social isolation or insecure immigration status 22.
This situation, although improbable because of the universal access
to healthcare, may  impact on diagnosis and access to HIV treat-
ment. The number of HIV infected women  reported as pregnant can
only be estimated from unlinked anonymous testing and there is no
institutionally established surveillance system to monitor mother
to child transmission although data are annually retrieved from
a clinicians’ managed data base of a cohort of mother and child
pairs.
This study has some limitations such as: birth rates by mother’s
country of birth (foreign and autochthonous) and place of current
residence could not be retrieved. Had this information been avail-
able it would have helped to better explain our ﬁndings.
More accurate estimates of HIV prevalence at district level and
not only at town or city level may  allow better targeting of resources
in bigger cities. This information was  not available from the data
collected until nowadays, although some changes have been pro-
posed from the year 2014 onwards.
In conclusion, this study reports on the only Catalan population-
based HIV prevalence data currently available for women giving
birth that has been carried out for two  decades; these data have
been a valuable tool for monitoring trends, targeting resources and
evaluating programs and policies.
e of current residence. 2007-2013.
a* Latin America** Rest of the world
lence Test N HIV + HIV Prevalence
% (95%CI)
Test N HIV + HIV Prevalence
% (95%CI)
-1,15) 4410 13 0,29 (0,16-0,50) 4910 4 0,08 (0,02-0,21)
-0,58) 3274 3 0,09 (0,02-0,27) 1677 2 0,12 (0,01-0,43)
-0,51) 8143 15 0,18 (0,10-0,30) 9453 15 0,16 (0,09-0,26)
, Algeria, Tunisia, Burkina Faso, Cameroon, The Gambia, Equatorial Guinea, Ghana,
 Chile, Colombia, Cuba, Dominican Republic, Ecuador, Panama, Paraguay, Peru and
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HIV prevalence in women giving birth in Catalonia continue to
ccur predominantly in women born abroad coming from countries
ith high HIV prevalence (ie: Sub-Saharan Africa) mirroring the
ituation of their country of origin.
The new Spanish legislation 23 denying health assistance to
igrants without residence permit may  reduce accessibility of vul-
erable women to care aggravating the situation of coming years.
urther studies should be developed to ascertain entrance and
etention to care of these HIV infected women giving birth.
This paper, as well as other studies4, underlines the value of
tudying populations’ origins in monitoring HIV prevalence in
iverse populations as well as the need to ensure reaching these
opulations on time.
What is known about the topic?
HIV unlinked anonymous testing of neonatal dried blood
spots taken for metabolic screening is simple, cheap and has
the added advantage of providing unbiased prevalence rates.
From 1994 to 2007 there has been a declining trend of HIV
prevalence among women giving birth in Catalonia.
What does this study add to the literature?
From 2008 onwards highest HIV prevalence rates were
among women born in Sub-Saharan Africa or Latin America
and living in Barcelona City and cities ≤ 200,000 inhabitants.
Therefore, antenatal and postnatal care should be maintained
and strengthened with special attention to ascertain entrance
and retention to care, addressing cultural and language barri-
ers of these HIV infected women giving birth.
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